Back to MPT Database

Subcutaneous Contraceptive and HIV Implant Engineered for Long-Acting Delivery (SCHIELD) device

Active Ingredient: TBD antiretroviral + hormone

Novel polymer reservoir MPT implant. Target 1 year duration.

Development Stage:

Preclinical – Early (Pre1)

Hormonal/Non-Hormonal:

Hormonal

Delivery Route & Method:

Systemic - Implant (Subcutaneous)

Mechanism of Action:

nucleoside reverse transcriptase inhibitor; ovulation suppression

Developer:

  • Research Triangle International (RTI)

Funding:

  • U.S. Agency for International Development (USAID)

Back to MPT Database